Announce Date | 03/05/2025 |
EPS Normalized Actual | $-0.01 (Miss by $-0.08) |
EPS GAAP Actual | $-0.01 (Miss by $-0.08) |
Revenue Actual | $2.01811B |
Revenue Surprise | Beat by $2018.11M |
Announce Date | 04/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.16594 |
EPS GAAP Estimate | $3.16594 |
Revenue Estimate | $3.204793525B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2027 | 12.25 | 6.59 | 11.31803 | 13.60499 | 1 |
Jul 2026 | 9.515 | 8.49 | 9.2 | 9.83 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.0581 | -1.2395 | 2.01811B | -9.38% | -383.58M |
FQ4 2024 (Oct 2024) | -0.0346 | -0.0346 | 2.14278B | -16.71% | 2142.78M |
FQ3 2024 (Jul 2024) | 0 | 0 | 2.53417B | -8.05% | 2534.17M |
FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 2.80111B | 100% | 2801.11M |
FQ1 2024 (Jan 2024) | 0.13 | 0.13 | 2.20737B | -6.31% | 2207.37M |
FQ4 2023 (Oct 2023) | 1.01 | 1.01 | 2.50076B | -24.29% | 2500.76M |
FQ3 2023 (Jul 2023) | 0 | 0 | 2.73807B | -39.58% | 2738.07M |
FQ4 2021 (Oct 2021) | 4.37 | 4.37 | 3.95822B | 100% | 3958.22M |
FQ4 Announce Date
04/30/2025 (Pre-Market)
Consensus EPS Estimates
3.16594
Consensus Revenue Estimates
3.204793525B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 2.9796 | -- | 2.75666 | 3.17684 | 11 |
FQ2 2027 (Apr 2027) | 3.165 | -- | 2.92819 | 3.37451 | 10 |
FQ1 2027 (Jan 2027) | 0.92 | -- | 0.82429 | 1.06063 | 5 |
FQ4 2026 (Oct 2026) | 1.2834 | -- | 1.18737 | 1.36836 | 9 |
FQ3 2026 (Jul 2026) | 2.58 | -- | 2.39905 | 2.79265 | 3 |
FQ2 2026 (Apr 2026) | 3.09 | -- | 2.87328 | 3.34468 | 6 |
FQ1 2026 (Jan 2026) | 1.61 | 103.61 | 1.49708 | 1.7427 | 3 |
FQ4 2025 (Oct 2025) | 1.72 | 102.01 | 1.59937 | 1.86177 | 4 |
FQ3 2025 (Jul 2025) | 2.9143 | -- | 2.71346 | 3.07248 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 2.95B | -- | 2.78B | 3.1B | 7 |
FQ2 2027 (Apr 2027) | 3.12B | -- | 2.94B | 3.28B | 12 |
FQ1 2027 (Jan 2027) | 2.31B | -- | 2.13B | 2.59B | 6 |
FQ4 2026 (Oct 2026) | 2.53B | -- | 2.38B | 2.65B | 7 |
FQ3 2026 (Jul 2026) | 2.88B | -- | 2.72B | 3.06B | 4 |
FQ2 2026 (Apr 2026) | 3.21B | -- | 3.03B | 3.41B | 7 |
FQ1 2026 (Jan 2026) | 2.45B | 17.79 | 2.32B | 2.61B | 4 |
FQ4 2025 (Oct 2025) | 2.71B | 20.82 | 2.56B | 2.88B | 3 |
FQ3 2025 (Jul 2025) | 3.08B | 17.69 | 2.92B | 3.21B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.1814 | -0.0581 | -1.2395 | 2133.39% |
FQ4 2024 (Oct 2024) | -0.0346 | -0.0346 | 100% | |
FQ3 2024 (Jul 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 100% | |
FQ1 2024 (Jan 2024) | 0.13 | 0.13 | 100% | |
FQ4 2023 (Oct 2023) | 1.01 | 1.01 | 100% | |
FQ3 2023 (Jul 2023) | 0 | 0 | NAN% | |
FQ4 2021 (Oct 2021) | 4.37 | 4.37 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $2.4B | $2.02B | $-383.58M | -19.01% |
FQ4 2024 (Oct 2024) | $0B | $2.14B | $2142.78M | 100% |
FQ3 2024 (Jul 2024) | $0B | $2.53B | $2534.17M | 100% |
FQ2 2024 (Apr 2024) | $0B | $2.8B | $2801.11M | 100% |
FQ1 2024 (Jan 2024) | $0B | $2.21B | $2207.37M | 100% |
FQ4 2023 (Oct 2023) | $0B | $2.5B | $2500.76M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.74B | $2738.07M | 100% |
FQ4 2021 (Oct 2021) | $0B | $3.96B | $3958.22M | 100% |